Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ADAM17 antibody (C-Term)

This Rabbit Polyclonal antibody specifically detects ADAM17 in WB, ELISA, FACS, ICC and IF. It exhibits reactivity toward Human, Rat and Mouse.It has been mentioned in 1 publication
Catalog No. ABIN1030720
$460.00
Plus shipping costs $50.00
0.1 mg
Shipping to: United States
Delivery in 2 to 3 Business Days

Quick Overview for ADAM17 antibody (C-Term) (ABIN1030720)

Target

See all ADAM17 Antibodies
ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))

Reactivity

  • 134
  • 61
  • 57
  • 3
  • 3
  • 3
  • 1
Human, Rat, Mouse

Host

  • 99
  • 26
  • 6
  • 5
  • 1
  • 1
Rabbit

Clonality

  • 81
  • 57
Polyclonal

Conjugate

  • 65
  • 9
  • 9
  • 8
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ADAM17 antibody is un-conjugated

Application

  • 96
  • 52
  • 48
  • 22
  • 22
  • 17
  • 16
  • 15
  • 15
  • 11
  • 4
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
  • Binding Specificity

    • 16
    • 8
    • 7
    • 7
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Specificity

    80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.

    Purification

    Affinity chromatography purified via peptide column
  • Application Notes

    TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C
  • McGowan, Mullooly, Caiazza, Sukor, Madden, Maguire, Pierce, McDermott, Crown, ODonovan, Duffy: "ADAM-17: a novel therapeutic target for triple negative breast cancer." in: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).

  • Target

    ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))

    Alternative Name

    TACE

    Molecular Weight

    Predicted: 93 kDa

    Pathways

    Notch Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
You are here:
Chat with us!